BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23876231)

  • 1. Synthesis, immunomodulation and cytotoxic effects of vanadium (IV) complexes.
    Ashiq U; Jamal RA; Mesaik MA; Mahroof-Tahir M; Shahid S; Khan KM
    Med Chem; 2014 May; 10(3):287-99. PubMed ID: 23876231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
    Holder AA; Taylor P; Magnusen AR; Moffett ET; Meyer K; Hong Y; Ramsdale SE; Gordon M; Stubbs J; Seymour LA; Acharya D; Weber RT; Smith PF; Dismukes GC; Ji P; Menocal L; Bai F; Williams JL; Cropek DM; Jarrett WL
    Dalton Trans; 2013 Sep; 42(33):11881-99. PubMed ID: 23783642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
    Le M; Rathje O; Levina A; Lay PA
    J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The syntheses and characterizations of vanadium complexes with 1,2-dihydroxyanthraquinone and the structure-effect relationship in their in vitro anticancer activities.
    Du S; Feng J; Lu X; Wang G
    Dalton Trans; 2013 Jul; 42(26):9699-705. PubMed ID: 23680987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dinuclear Ru
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.
    Bakhshi Aliabad H; Khanamani Falahati-Pour S; Ahmadirad H; Mohamadi M; Hajizadeh MR; Mahmoodi M
    Biometals; 2018 Dec; 31(6):981-990. PubMed ID: 30255365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
    Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
    Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate heteroligands.
    Andrezálová L; Gbelcová H; Duračková Z
    J Trace Elem Med Biol; 2013 Jan; 27(1):21-6. PubMed ID: 22575540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4'-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2':6',2″-terpyridine.
    Chu W; Wang Y; Liu S; Yang X; Wang S; Li S; Zhou G; Qin X; Zhou C; Zhang J
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5187-91. PubMed ID: 23927970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
    Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
    J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of antitumor effect of selected vanadium and molybdenum organometallic complexes in human leukemic T-cells.
    Šebestová L; Havelek R; Řezáčová M; Honzíček J; Kročová Z; Vinklárek J
    Chem Biol Interact; 2015 Dec; 242():61-70. PubMed ID: 26391003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
    Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
    Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiproliferative effect of vanadium complexes bearing 8-hydroxyquinoline-based ligands - the substituent effect.
    Choroba K; Raposo LR; Palion-Gazda J; Malicka E; Erfurt K; Machura B; Fernandes AR
    Dalton Trans; 2020 May; 49(20):6596-6606. PubMed ID: 32342090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadium(IV/V) complexes of Triapine and related thiosemicarbazones: Synthesis, solution equilibrium and bioactivity.
    Kowol CR; Nagy NV; Jakusch T; Roller A; Heffeter P; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2015 Nov; 152():62-73. PubMed ID: 26349014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of substitution at terminal nitrogen of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde thiosemicarbazones on the coordination behavior and structure and biological properties of their palladium(II) complexes.
    Ramachandran E; Senthil Raja D; Rath NP; Natarajan K
    Inorg Chem; 2013 Feb; 52(3):1504-14. PubMed ID: 23323516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage.
    Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC
    Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)].
    Noblía P; Vieites M; Parajón-Costa BS; Baran EJ; Cerecetto H; Draper P; González M; Piro OE; Castellano EE; Azqueta A; López de Ceráin A; Monge-Vega A; Gambino D
    J Inorg Biochem; 2005 Feb; 99(2):443-51. PubMed ID: 15621276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
    Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
    Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures and anti-cancer properties of two binuclear copper complexes.
    Qin XY; Yang LC; Le FL; Yu QQ; Sun DD; Liu YN; Liu J
    Dalton Trans; 2013 Oct; 42(41):14681-4. PubMed ID: 24026617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
    Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
    Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.